Results 201 to 210 of about 23,969 (235)
Some of the next articles are maybe not open access.

Non-Infectious Uveitis: Optimising the Therapeutic Response

Drugs, 2015
Non-infectious uveitis mainly affects the working-age population and can contribute to significant social and economic burden. It comprises a heterogeneous group of conditions with varied aetiology. Precise and early diagnosis, excluding masquerade syndromes, is the key to early therapeutic intervention.
Archana, Airody   +3 more
openaire   +2 more sources

General Principles for the Treatment of Non-Infectious Uveitis

Inflammation & Allergy-Drug Targets, 2009
Ocular inflammatory disorders constitute a sight-threatening group of diseases that might be managed according to their severity. Their treatment guidelines experience constant changes with new agents that improve the results obtained with former drugs.
Manuel, Díaz-Llopis   +3 more
openaire   +2 more sources

Infectious and non infectious triggers in non‐infectious uveitis

Acta Ophthalmologica, 2010
Abstract Purpose The induction of autoimmune uveitis is difficult to explain with respect to the immune privileged status of the eye. The intact BRB can only be passed by already activated leukocytes, which should normally be ignorant to the sequestered intraocular antigens.
openaire   +1 more source

Intravitreal dexamethasone implants for non‐infectious uveitis

Clinical & Experimental Ophthalmology, 2019
AbstractImportanceInflammatory‐mediated cystoid macular oedema (CMO) is the most common inflammatory‐mediated threat to vision in non‐infectious uveitis (NIU). Corticosteroid therapy is the cornerstone to the management of CMO in NIU. Sustained‐release dexamethasone (DEX) implant devices provide localized therapy.BackgroundThe authors present a series ...
Matthew McCartney   +2 more
openaire   +2 more sources

Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients

Pediatric Drugs, 2023
Uveitis in children accounts for 5-10% of all cases. The causes vary considerably. Classically, uveitis is distinguished according to its infectious or inflammatory origin and whether it is part of a systemic disease or represents an isolated ocular disease.
Ai Tien Nguyen   +2 more
openaire   +2 more sources

Non‐infectious causes of uveitis in 70 Swiss children

Acta Paediatrica, 2000
Many diseases are linked with uveitis, but few studies have specifically looked at the noninfectious triggers of childhood uveitis in Central Europe. The charts of 70 paediatric patients with non‐infectious uveitis admitted to the Department of Pediatrics, University of Bern, Switzerland, between 1983 and 1998 were therefore reviewed.
Stoffel PB   +5 more
openaire   +3 more sources

Chronic Non-Infectious Uveitis in the Elderly

Drugs & Aging, 2006
Intraocular inflammatory diseases are collectively known as uveitis. The aetiology of this condition can be diverse, as inflammation may result from direct involvement of the uveal tract or indirect inflammation of adjacent tissues. Uveitis can present challenges to diagnosis and treatment, and is potentially a severe sight-threatening disease.
Rajen, Gupta, Philip I, Murray
openaire   +2 more sources

Intravitreal immunotherapy in non-infectious uveitis

Expert Review of Clinical Pharmacology, 2023
Introduction: In the past several years, there have been numerous advances in pharmacotherapeutics for the management of uveitis and other ocular inflammatory diseases, including newer therapeutic agents and ocular drug delivery systems. One of the most attractive modes of drug delivery is the intravitreal route since it has proven to be safe and ...
Menia, Nitin Kumar   +2 more
openaire   +1 more source

Non-Infectious Uveitis

2023
Yael Sharon, Michal Kramer
openaire   +1 more source

Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis

BioDrugs, 2017
Adalimumab (Humira®) is a tumour necrosis factor (TNF)-α inhibitor available in various countries worldwide, including the USA, Japan and those of the EU, for the treatment of non-infectious intermediate, posterior and panuveitis in adults. It is the first biological agent approved for this indication.
openaire   +2 more sources

Home - About - Disclaimer - Privacy